Company Filing History:
5 out of 132 
3 out of 3 
3 out of 321 
Years Active: 1999-2025
Title: Inventor Profile: Antoine Lafont
Introduction
Antoine Lafont is a renowned inventor based in Paris, France, known for his groundbreaking contributions to the field of cell therapies. With an impressive portfolio of 15 patents, Lafont has dedicated his career to advancing the understanding and application of mammalian cell populations, particularly in equines and canines.
Latest Patents
Among his latest patents, Lafont has focused on two significant innovations: “Mammalian cell population and medicaments for cell therapies in equines” and “Mammalian cell population and medicaments for cell therapies in canines.”
These compositions involve cell populations derived from equine and canine gingival fibroblasts that display unique phenotypes. These specially selected cells express proteins that promote angiogenesis and have anti-inflammatory effects while minimizing cell populations that could lead to tumor formation or impede tissue regeneration. Moreover, Lafont's methods significantly enhance cell proliferation compared to earlier techniques, providing promising avenues for various equine and canine cell therapies.
Career Highlights
Antoine Lafont's career is marked by his association with prestigious institutions, notably the Université Paris Descartes, where he has contributed to significant research initiatives. He has also worked at Arterial Remodelling Technologies, Inc., a company striving to innovate in the field of vascular health.
Collaborations
Throughout his career, Lafont has collaborated with esteemed colleagues including Bruno Gogly and Bernard Coulomb. These partnerships have allowed him to leverage diverse expertise and push the boundaries of current medical therapies.
Conclusion
In summary, Antoine Lafont stands out as a prolific inventor with a focus on innovative solutions in cell therapy. His patents contribute significantly to advancements in veterinary medicine, particularly in equine and canine health. With ongoing research and development, Lafont's work continues to have a lasting impact on the field.